Anlon Healthcare IPO: The Anlon Healthcare IPO has been gaining strong investor traction since its opening. By Day 2, the IPO was already subscribed 3.30 times, showing a solid response from retail investors, non-institutional investors (NIIs), and qualified institutional buyers (QIBs). The grey market premium (GMP) is also reflecting positive investor sentiment, pointing toward a likely healthy listing.
In this detailed guide, we’ll cover:
- ✅ Subscription status (Day 1 & Day 2 updates)
- ✅ IPO price band & key dates
- ✅ GMP trend & estimated listing price
- ✅ Brokerage reviews & expert opinions
- ✅ Company fundamentals & valuation
- ✅ Should you apply or avoid?
📌 Anlon Healthcare IPO Subscription Status
The IPO saw a steady rise in subscriptions right from the opening day. Here’s how the response looked so far:
🗓️ Day 1 (Aug 26) Subscription
- Overall: 1.69x subscribed
- Retail: 8.99x ✅ Strong demand
- Non-Institutional Investors (NII): 71%
- Qualified Institutional Buyers (QIB): 91%
🗓️ Day 2 (Aug 27) Subscription (Till 5 PM)
- Overall: 3.30x subscribed
- Retail: 22.32x 💥
- NII: 2.09x
- QIB: 1.01x
📉 Total bids received:
4,39,34,124 shares vs. 1,33,00,000 shares on offer (BSE data).
👉 The retail portion is seeing massive demand, indicating strong retail confidence in the company.
📅 Important IPO Dates
| Event | Date |
|---|---|
| IPO Open | Tuesday, Aug 26 |
| IPO Close | Friday, Aug 29 |
| Allotment Finalisation | Monday, Sept 1 |
| Refunds Begin | Tuesday, Sept 2 |
| Demat Credit | Tuesday, Sept 2 |
| Listing (Expected) | Early September |
⏳ Investors should keep track of the allotment and listing dates to know their chances of receiving shares.
💰 Anlon Healthcare IPO Price Band & Offer Size
- Price Band: ₹86 – ₹91 per share (Face Value: ₹10)
- Offer Size: Approx. ₹121 crore
- Shares Offered: 1.33 crore (Fresh Issue)
🏦 Share Allocation Structure
- QIBs: 75%
- NIIs: 15%
- Retail: 10%
📊 The higher QIB allocation ensures institutional participation, while retail investors get a smaller 10% quota. However, retail bids have oversubscribed many times, highlighting investor enthusiasm.
🔥 Grey Market Premium (GMP) Today
- Current GMP: +₹5
- Upper Price Band: ₹91
- Expected Listing Price: ₹96 (≈ 5.49% premium)
📈 Over the last 8 sessions, GMP has been moving upward, with ₹5 as the maximum. The grey market suggests a strong listing potential.
👉 What is GMP?
Grey Market Premium (GMP) reflects how much investors are willing to pay above the IPO issue price in the unofficial market. A positive GMP indicates investor confidence and expectations of a strong debut.
🏭 About Anlon Healthcare
Anlon Healthcare operates in the healthcare and pharmaceutical manufacturing sector, which is known for strict compliance requirements and long client approval cycles.
- The company manufactures specialized medical consumables and healthcare products.
- Its business is supported by strong demand from hospitals, diagnostic centers, and pharma companies.
- Operating in a sector with high entry and exit barriers, the company enjoys stability against new competitors.
📈 Company Valuation & Financials
According to Anand Rathi Research:
- EV/EBITDA: 16.7x
- P/E Ratio: 19.0x (based on FY25 earnings, upper price band)
- Post-Issue Market Cap: ₹4,836 million
💡 Interpretation:
The valuation looks fair compared to peers, with scope for growth due to strong sector demand.
🧐 Expert Review: Apply or Avoid?
🔍 Brokerage View
- Anand Rathi Research: Subscribe for Long Term
- Rationale:
- Fairly valued IPO
- Strong industry fundamentals
- Entry/exit barriers in the healthcare sector ensure long-term growth
📊 Investor Sentiment
- Retail investors are showing huge interest (22.32x oversubscription by Day 2).
- GMP trends suggest listing gains are possible, though not very high.
🏭 IPO Objectives: Where Will the Funds Go?
The company plans to raise ₹121 crore through this IPO. The proceeds will be used as follows:
- 🏗️ Expansion of manufacturing facility: ₹30.7 crore
- 💼 Working capital enhancement: ₹43.15 crore
- 💳 Debt repayment: Balance amount
- 📊 General corporate purposes
👉 This indicates a focus on capacity building and strengthening the balance sheet, which is positive for long-term growth.
📊 Anlon Healthcare IPO – Quick Snapshot
| Particulars | Details |
|---|---|
| IPO Dates | Aug 26 – Aug 29 |
| Price Band | ₹86 – ₹91 |
| Lot Size | To be announced |
| Issue Size | ₹121 crore |
| Shares Offered | 1.33 crore |
| Allotment Date | Sept 1 |
| Listing Date | Sept 2 onwards |
| GMP Today | +₹5 |
| Expected Listing Price | ₹96 |
| Oversubscription (Day 2) | 3.30x |
| Retail Subscription (Day 2) | 22.32x |
| NII Subscription (Day 2) | 2.09x |
| QIB Subscription (Day 2) | 1.01x |
| Lead Manager | Interactive Financial Services |
| Sector | Healthcare / Pharma Manufacturing |
⚖️ Pros & Cons of Anlon Healthcare IPO
✅ Pros
- Strong demand from retail investors
- Operating in a defensive, evergreen sector (healthcare)
- High entry barriers limit competition
- Reasonable valuation compared to industry peers
- Positive GMP indicating listing gains
❌ Cons
- Retail allocation only 10% → Allotment chances low
- GMP premium is modest (5.5%) – listing gains may be limited
- Heavy dependence on regulatory approvals
- Sector requires continuous compliance, which could be costly
📝 Final Verdict: Should You Apply?
The Anlon Healthcare IPO has:
- 👍 Strong investor demand (22x retail oversubscription)
- 👍 Positive brokerage recommendation (Subscribe for Long Term)
- 👍 Fair valuation with healthy growth prospects
However:
- ⚠️ Retail allotment is small → chances of getting shares are slim
- ⚠️ GMP premium is modest, meaning listing gains may not be huge
👉 Verdict: If you’re a long-term investor, this IPO is worth applying for. For short-term listing gains, expectations should be moderate.
📢 Disclaimer
The above analysis is based on market data and brokerage views. IPO investments carry market risks. Investors should consult a SEBI-registered financial advisor before applying.
